Skip to main content
. 2016 Sep 1;354:i4351. doi: 10.1136/bmj.i4351

Table 4.

Excess mortality ratios from univariable and multivariable Poisson models assessing the risk of all, recurrence or progression, subsequent primary neoplasm, and non-neoplastic causes of death by treatment period

Treatment period All causes Recurrence or progression Subsequent primary neoplasms Non-neoplastic causes
Observed/expected Univariable: EMR (95% CI) Multivariable*: EMR (95% CI) Observed/expected Univariable: EMR (95% CI) Multivariable*: EMR (95% CI) Observed/expected Univariable: EMR (95% CI) Multivariable*: EMR (95% CI) Observed/expected Univariable: EMR (95% CI) Multivariable*: EMR (95% CI)
<1970 1329/228.1 1 (ref) 1 (ref) 638/0.0 1 (ref) 1 (ref) 295/79.7 1 (ref) 1 (ref) 396/148.5 1 (ref) 1 (ref)
1970-79 1247/125.0 0.9 (0.8 to 1.0) 0.8 (0.7 to 0.8) 708/0.0 1.0 (0.9 to 1.1) 0.7 (0.6 to 0.7) 240/26.9 0.9 (0.7 to 1.1) 1.4 (1.1 to 1.7) 299/98.1 0.7 (0.6 to 0.9) 1.0 (0.8 to 1.3)
1980-89 942/85.0 0.7 (0.6 to 0.7) 0.5 (0.5 to 0.6) 591/0.0 0.8 (0.7 to 0.9) 0.4 (0.4 to 0.5) 138/13.1 0.5 (0.4 to 0.6) 0.9 (0.7 to 1.2) 213/71.9 0.5 (0.4 to 0.6) 0.9 (0.7 to 1.2)
1990-2006 957/52.9 0.6 (0.6 to 0.7) 0.3 (0.3 to 0.4) 689/0.0 0.8 (0.7 to 0.9) 0.3 (0.2 to 0.3) 122/7.3 0.4 (0.3 to 0.5) 0.9 (0.7 to 1.2) 146/45.5 0.3 (0.2 to 0.4) 0.6 (0.4 to 0.8)
P for trend† <0.01 <0.01 <0.01 <0.01 <0.01 0.10 <0.01 <0.01

EMR=excess mortality ratios.

*Adjusted for sex, first primary neoplasm diagnosis, age at diagnosis, and attained age.

†Calculated using likelihood ratio tests to assess the effect of treatment period.